F19.931 Other psychoactive substance use, unspecified with withdrawal delirium

Name of the Condition

• Other Psychoactive Substance Use, Unspecified with Withdrawal Delirium
• ICD-10 Code: F19.931

Summary

This condition involves the use of a psychoactive substance not classified under more specific categories (e.g., alcohol, cannabis, opioids) where the substance is unidentified, and withdrawal delirium is present. It is classified as "unspecified" when the exact agent is unknown or not documented, "with withdrawal" indicates physiological or psychological symptoms that occur after reducing or stopping use of the substance, and "delirium" denotes an acute, fluctuating disturbance in attention and awareness with cognitive changes.

Causes

The condition may result from experimentation, recreational use, or habitual consumption of various psychoactive substances. These substances can alter perception, mood, cognition, or behavior, though the specific agent is not specified. Withdrawal delirium occurs when the body adapts to the substance and experiences severe symptoms when use is reduced or stopped, often due to abrupt cessation or reduced intake.

Risk Factors

• Peer pressure or cultural acceptance of substance use.
• Stressful life circumstances or co-occurring mental health conditions (e.g., anxiety, depression).
• Availability of and access to psychoactive substances.
• History of substance use disorders or prior withdrawal episodes.

Symptoms

Symptoms vary based on the substance but may include altered perception, mood swings, impaired judgment, or changes in behavior. Withdrawal-specific symptoms can include cravings, irritability, anxiety, or physical discomfort. Delirium symptoms may involve confusion, disorientation, hallucinations, or fluctuating consciousness.

Diagnosis

Diagnosis typically involves a clinical assessment, including patient history and behavioral observations. Lab tests may be used if the substance identity is unknown, though no specific tests are standard. Delirium is identified through evaluation of attention, awareness, and cognitive changes, often requiring exclusion of other causes (e.g., infection, metabolic disturbances).

Treatment Options

• Medical Stabilization: Address acute symptoms, including monitoring for safety and managing agitation or confusion.
• Pharmacotherapy: Use medications to alleviate withdrawal symptoms or delirium, tailored to the patient’s condition.
• Supportive Care: Ensure hydration, nutrition, and a safe environment to reduce distress.
• Behavioral Interventions: Initiate counseling or therapy to address substance use patterns and prevent recurrence.

Prognosis and Follow-Up

Prognosis depends on the severity of delirium, underlying health, and response to treatment. Early intervention improves outcomes, but delirium can increase morbidity. Follow-up care should include monitoring for relapse, ongoing substance use treatment, and addressing co-occurring conditions.

Complications

• Severe cognitive impairment or prolonged confusion.
• Increased risk of injury due to disorientation or agitation.
• Worsening of co-occurring mental or physical health conditions.
• Potential for recurrence if substance use continues.

Lifestyle & Prevention

• Avoid use of unidentified psychoactive substances.
• Seek help for substance use concerns early to prevent withdrawal.
• Maintain a stable routine and support system to reduce stress.
• Follow medical guidance for tapering or discontinuing substance use to minimize withdrawal risks.

When to Seek Professional Help

Seek immediate medical attention if experiencing confusion, hallucinations, severe agitation, or other signs of delirium. Contact a healthcare provider for persistent withdrawal symptoms or concerns about substance use.

Tips for Medical Coders

Document the presence of withdrawal delirium clearly, including clinical findings (e.g., fluctuating consciousness, cognitive changes) and substance use history. Ensure "unspecified" is used only when the psychoactive agent is unknown or not documented. Code F19.931 when delirium is a direct result of withdrawal from an unspecified psychoactive substance.